Opus Point Partners Management

Opus Point Partners Management as of June 30, 2019

Portfolio Holdings for Opus Point Partners Management

Opus Point Partners Management holds 62 positions in its portfolio as reported in the June 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
iShares NASDAQ Biotechnology Index (IBB) 33.9 $23M 210k 109.11
Direxion Shs Etf Tr sp biotch bl 7.3 $4.9M 98k 50.19
Mettler-Toledo International (MTD) 4.0 $2.7M 3.2k 839.88
Illumina (ILMN) 2.6 $1.7M 4.7k 368.16
Vertex Pharmaceuticals Incorporated (VRTX) 2.2 $1.5M 8.2k 183.33
Bristol Myers Squibb (BMY) 2.2 $1.5M 33k 45.36
Alexion Pharmaceuticals 1.9 $1.3M 9.9k 130.96
Ionis Pharmaceuticals (IONS) 1.9 $1.3M 20k 64.25
Proqr Thrapeutics N V shs euro (PRQR) 1.9 $1.3M 139k 9.10
Seattle Genetics 1.8 $1.2M 18k 69.21
Qiagen Nv (QGEN) 1.7 $1.2M 29k 40.54
Uniqure Nv (QURE) 1.6 $1.1M 14k 78.16
EXACT Sciences Corporation (EXAS) 1.5 $1.0M 8.5k 118.00
Spark Therapeutics 1.5 $993k 9.7k 102.38
Alnylam Pharmaceuticals (ALNY) 1.4 $969k 13k 72.58
Incyte Corporation (INCY) 1.3 $902k 11k 84.99
Immunomedics 1.3 $868k 63k 13.87
Sarepta Therapeutics (SRPT) 1.2 $813k 5.4k 151.88
BioMarin Pharmaceutical (BMRN) 1.2 $805k 9.4k 85.64
Bluebird Bio (BLUE) 1.1 $743k 5.8k 127.23
Ascendis Pharma A S (ASND) 1.1 $713k 6.2k 115.19
Regeneron Pharmaceuticals (REGN) 1.0 $695k 2.2k 312.92
Insmed (INSM) 1.0 $690k 27k 25.62
Audentes Therapeutics 1.0 $656k 17k 37.83
Blueprint Medicines (BPMC) 0.9 $640k 6.8k 94.40
G1 Therapeutics (GTHX) 0.9 $639k 21k 30.66
Epizyme 0.9 $632k 50k 12.55
Gw Pharmaceuticals Plc ads 0.9 $633k 3.7k 172.29
Crispr Therapeutics (CRSP) 0.9 $622k 13k 47.07
Arena Pharmaceuticals 0.8 $573k 9.8k 58.65
Celgene Corporation 0.8 $520k 5.6k 92.44
Macrogenics (MGNX) 0.8 $510k 30k 16.96
Global Blood Therapeutics In 0.7 $499k 9.5k 52.64
Pacira Pharmaceuticals (PCRX) 0.7 $489k 11k 43.47
Biohaven Pharmaceutical Holding 0.7 $475k 11k 43.77
Intercept Pharmaceuticals In 0.7 $467k 5.9k 79.53
Zogenix 0.7 $465k 9.7k 47.81
Intellia Therapeutics (NTLA) 0.7 $466k 29k 16.36
Amicus Therapeutics (FOLD) 0.7 $458k 37k 12.47
Nektar Therapeutics (NKTR) 0.7 $445k 13k 35.59
Deciphera Pharmaceuticals (DCPH) 0.6 $420k 19k 22.54
Viking Therapeutics (VKTX) 0.6 $402k 49k 8.29
Madrigal Pharmaceuticals (MDGL) 0.6 $374k 3.6k 104.76
Fortress Biotech 0.5 $351k 234k 1.50
Anaptysbio Inc Common (ANAB) 0.5 $345k 6.1k 56.41
Checkpoint Therapeutics 0.5 $342k 113k 3.03
Amarin Corporation (AMRN) 0.5 $323k 17k 19.41
Ultragenyx Pharmaceutical (RARE) 0.5 $322k 5.1k 63.59
Bio-techne Corporation (TECH) 0.5 $323k 1.6k 208.25
ACADIA Pharmaceuticals (ACAD) 0.5 $320k 12k 26.71
Iqvia Holdings (IQV) 0.5 $319k 2.0k 160.71
Charles River Laboratories (CRL) 0.4 $300k 2.1k 142.05
Gilead Sciences (GILD) 0.4 $276k 4.1k 67.61
Grifols S A Sponsored Adr R (GRFS) 0.4 $278k 13k 21.07
Biogen Idec (BIIB) 0.4 $263k 1.1k 234.19
Amgen (AMGN) 0.4 $257k 1.4k 183.97
Neurocrine Biosciences (NBIX) 0.4 $254k 3.0k 84.33
Exelixis (EXEL) 0.4 $244k 11k 21.33
Ligand Pharmaceuticals In (LGND) 0.4 $241k 2.1k 114.16
Agios Pharmaceuticals (AGIO) 0.4 $240k 4.8k 49.94
Fibrogen (FGEN) 0.3 $221k 4.9k 45.26
Recro Pharma (SCTL) 0.2 $115k 11k 10.13